{
  "id": "map_1887",
  "title": "Flujogramas de Manejo de\\NPatolog√≠a Neurol√≥gica",
  "specialty": "Neurolog√≠a",
  "tag": "üìã Gu√≠a Cl√≠nica",
  "node_count": 169,
  "root": {
    "text": "Flujogramas de Manejo de\\NPatolog√≠a Neurol√≥gica",
    "children": [
      {
        "text": "Criterios de Ingreso Unidad de Paciente Neurocr√≠tico\\N(UTIN H2)",
        "children": [
          {
            "text": "1. Neurol√≥gicos",
            "children": [
              {
                "text": "a. Guillain Barr√© y variantes",
                "children": []
              },
              {
                "text": "b. Crisis miast√©nica",
                "children": []
              },
              {
                "text": "c. Encefalitis herp√©tica o autoinmune",
                "children": []
              },
              {
                "text": "d. Infarto encef√°lico extenso y/o de comportamiento maligno\\N(ACM completa / PICA)",
                "children": []
              },
              {
                "text": "e. Hemorragia intracerebral con requerimientos de intervenci√≥n quir√∫rgica",
                "children": []
              },
              {
                "text": "f. Status epil√©ptico",
                "children": []
              },
              {
                "text": "g. Epilepsia descompensada con necesidad de monitorizaci√≥n cl√≠nica y EEG",
                "children": []
              },
              {
                "text": "h. Trombosis venosa cerebral",
                "children": []
              },
              {
                "text": "i. Enfermedad desmielinizante que requiera tratamiento inmunomodulador o PLEX",
                "children": []
              },
              {
                "text": "j. Realizaci√≥n de test de Katzman",
                "children": []
              },
              {
                "text": "k. Monitorizaci√≥n EEG continuo electivo",
                "children": []
              },
              {
                "text": "l. Infusi√≥n de medicamentos biol√≥gicos (Alemtuzumab, Ocrelizumab, entre otros)",
                "children": []
              }
            ]
          },
          {
            "text": "2. Neuroquir√∫rgicos",
            "children": [
              {
                "text": "a. Hemorragia subaracnoidea",
                "children": []
              },
              {
                "text": "b. Tumores sistema nervioso central descompensados o postoperados",
                "children": []
              },
              {
                "text": "c. Traumatismo encefalocraneano moderado/grave o complicado",
                "children": []
              },
              {
                "text": "d. Trauma raquimedular o cirug√≠a de columna traum√°tica",
                "children": []
              },
              {
                "text": "e. Manejo de drenaje ventricular o espinal",
                "children": []
              },
              {
                "text": "f. Manejo postoperatorio de macroadenoma hipofisiario",
                "children": []
              },
              {
                "text": "g. Infecciones SNC asociados a intervenci√≥n quir√∫rgica",
                "children": []
              },
              {
                "text": "h. Manejo postquir√∫rgico de dispositivos de estimulaci√≥n cerebral",
                "children": []
              },
              {
                "text": "i. Manejo post procedimiento de Neurorradiolog√≠a intervencional\\N(embolizaci√≥n, coils, diversor de flujo, stent, diagn√≥sticas seg√∫n necesidad)",
                "children": []
              }
            ]
          },
          {
            "text": "**Pacientes con criterios UTI neuro pero sin disponibilidad de camas,\\Ntienen indicaci√≥n de cama UTI m√©dica (no UTAC)",
            "children": []
          }
        ]
      },
      {
        "text": "Criterios de Ingreso Unidad de Tratamiento del Ataque Cerebrovascular\\N(UTAC H5)",
        "children": [
          {
            "text": "1. ACV en ventana de trombolisis",
            "children": []
          },
          {
            "text": "2. TIA alto riesgo < 3 d√≠as",
            "children": []
          },
          {
            "text": "3. Infarto lacunar < 3 d√≠as",
            "children": []
          },
          {
            "text": "4. Infarto cerebral extenso < 5 d√≠as no maligno",
            "children": []
          },
          {
            "text": "5. Infarto de tronco < 5 d√≠as",
            "children": []
          },
          {
            "text": "6. Infarto bulbar < 7 d√≠as",
            "children": []
          },
          {
            "text": "7. Infarto cerebeloso AICA o SUCA\\N(PICA s√≥lo a criterio de neur√≥logo IC)",
            "children": []
          },
          {
            "text": "8. Hemorragia intracerebral < 3 d√≠as o con\\Nrequerimientos de antihipertensivos IV",
            "children": []
          },
          {
            "text": "9. Trombosis venosa cerebral\\N(con o sin infarto asociado)",
            "children": []
          },
          {
            "text": "*Pacientes con criterios UTAC pero sin disponibilidad de camas,\\Ntienen indicaci√≥n de cama UTIN (no UTI m√©dica)",
            "children": []
          }
        ]
      },
      {
        "text": "Flujograma Vasoespasmo\\NSintom√°tico",
        "children": [
          {
            "text": "Elementos cl√≠nicos de\\Nvasoespasmo sintom√°tico",
            "children": [
              {
                "text": "Territorio Vascular\\NElementos Cl√≠nicos",
                "children": [
                  {
                    "text": "Arteria Cerebral Anterior y\\NComunicante Anterior",
                    "children": [
                      {
                        "text": "Cuadro confusional no explicable por otra causa",
                        "children": []
                      },
                      {
                        "text": "S√≠ndrome febril no explicado",
                        "children": []
                      },
                      {
                        "text": "Apat√≠a, abulia inatenci√≥n",
                        "children": []
                      },
                      {
                        "text": "Cambios conductuales con agresividad o retraimiento",
                        "children": []
                      },
                      {
                        "text": "Hemiparesia disarm√≥nica de predominio crural",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "Arteria Cerebral\\NMedia",
                    "children": [
                      {
                        "text": "Hemiparesia contralateral\\Ndisarm√≥nica de predominio crural",
                        "children": []
                      },
                      {
                        "text": "Afasia (si lado izquierdo)",
                        "children": []
                      },
                      {
                        "text": "Hipoalgesia contralateral",
                        "children": []
                      },
                      {
                        "text": "Hemianopsia hom√≥nima contralateral",
                        "children": []
                      },
                      {
                        "text": "Heminegligencia (si lado derecho)",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "Arteria Cerebral\\NPosterior",
                    "children": [
                      {
                        "text": "Hemianopsia hom√≥nima contralateral\\N(que respeta visi√≥n macular)",
                        "children": []
                      },
                      {
                        "text": "Amaurosis (si compromiso bilateral)",
                        "children": []
                      },
                      {
                        "text": "Cefalea",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "Arteria Basilar y\\NVertebrales",
                    "children": [
                      {
                        "text": "Disartria",
                        "children": []
                      },
                      {
                        "text": "Nistagmus",
                        "children": []
                      },
                      {
                        "text": "Compromiso de conciencia",
                        "children": []
                      },
                      {
                        "text": "Cefalea",
                        "children": []
                      },
                      {
                        "text": "Ataxia",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Simuladores de\\NVasoespasmo",
                "children": [
                  {
                    "text": "Hidrocefalia",
                    "children": []
                  },
                  {
                    "text": "Fiebre de origen infeccioso",
                    "children": []
                  },
                  {
                    "text": "Edema con hipertensi√≥n intracraniana",
                    "children": []
                  },
                  {
                    "text": "Hipo/hipernatremia",
                    "children": []
                  },
                  {
                    "text": "Crisis convulsiva",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "Objetivar\\NVasoespasmo",
            "children": [
              {
                "text": "Objetivar vasoespasmo mediante\\NDTC, angioTC o angiograf√≠a",
                "children": []
              }
            ]
          },
          {
            "text": "Manejo",
            "children": [
              {
                "text": "Inicial",
                "children": [
                  {
                    "text": "PAM m√°s de 20% del basal",
                    "children": [
                      {
                        "text": "(ideal sobre 100-120)",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "Correcci√≥n del Medio interno",
                    "children": [
                      {
                        "text": "Hipovolemia, hipertermia,\\Nhiponatremia, hipomagnasemia",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "Descartar Factores Contundentes",
                    "children": []
                  }
                ]
              },
              {
                "text": "Reevaluaci√≥n Cl√≠nica\\Ncada 30-60 minutos",
                "children": [
                  {
                    "text": "Persiste D√©ficit",
                    "children": [
                      {
                        "text": "Titular NAD para PAM 120-130",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "Persiste D√©ficit",
                    "children": [
                      {
                        "text": "Manejo Vasoespasmo Refractario",
                        "children": []
                      },
                      {
                        "text": "Angioplast√≠a de\\NEmergencia",
                        "children": [
                          {
                            "text": "Factible",
                            "children": [
                              {
                                "text": "Traslado Pabell√≥n Hemodinamia",
                                "children": []
                              }
                            ]
                          },
                          {
                            "text": "No Factible",
                            "children": [
                              {
                                "text": "Protocolo Milrinona",
                                "children": []
                              }
                            ]
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Flujograma Milrinona en\\NVasoespasmo Sintom√°tico",
                "children": [
                  {
                    "text": "Asegurar PAM 100-120 con NAD",
                    "children": []
                  },
                  {
                    "text": "Milrinona Intravenosa",
                    "children": [
                      {
                        "text": "Iniciar Milrinona a 0.5 mcg/kg/min",
                        "children": []
                      },
                      {
                        "text": "Persiste D√©ficit",
                        "children": [
                          {
                            "text": "Ascenso gradual en 0.25 mcg/kg/min",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "Persiste D√©ficit",
                        "children": [
                          {
                            "text": "Titular hasta 1.25 mcg/kg/min dosis m√°xima",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "Consideraciones",
                    "children": [
                      {
                        "text": "Siempre priorizar PAM sobre uso de milrinona.",
                        "children": []
                      },
                      {
                        "text": "Si respuesta inodilatadora tras uso de milrinona genera hipotensi√≥n relativa,\\Nsuspender y priorizar vasopresor",
                        "children": []
                      },
                      {
                        "text": "En caso de iniciar milrinona, siempre asegurar m√≠nimo PAM 90-100,\\Ncon vasopresor de ser necesario",
                        "children": []
                      },
                      {
                        "text": "Reevaluar cl√≠nicamente cada 60-120 minutos",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Flujograma de Manejo de Crisis Convulsiva\\Nen Urgencia y Hospitalizados",
        "children": [
          {
            "text": "Crisis de Inicio\\NObjetivado",
            "children": [
              {
                "text": "HGT + Tiamina",
                "children": []
              },
              {
                "text": "Resoluci√≥n Crisis\\Ndentro de 3-5 minutos",
                "children": [
                  {
                    "text": "Si ‚Üí Estudio",
                    "children": []
                  },
                  {
                    "text": "No ‚Üí Dosis BZD",
                    "children": []
                  }
                ]
              },
              {
                "text": "Resoluci√≥n crisis\\Ndentro de 3-5 minutos",
                "children": [
                  {
                    "text": "Si ‚Üí Estudio",
                    "children": []
                  },
                  {
                    "text": "No ‚Üí Referirse a Flujograma Status Epil√©ptico",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "Crisis de Inicio Desconocido\\No m√°s de 5 minutos",
            "children": [
              {
                "text": "HGT + BZD + Tiamina",
                "children": []
              },
              {
                "text": "Resoluci√≥n Crisis\\Ndentro de 3-5 minutos",
                "children": [
                  {
                    "text": "Si ‚Üí Estudio",
                    "children": []
                  },
                  {
                    "text": "No ‚Üí Nueva dosis BZD",
                    "children": []
                  }
                ]
              },
              {
                "text": "Resoluci√≥n crisis\\Ndentro de 3-5 minutos",
                "children": [
                  {
                    "text": "Si ‚Üí Estudio",
                    "children": []
                  },
                  {
                    "text": "No ‚Üí Referirse a Flujograma Status Epil√©ptico",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "Notas",
            "children": [
              {
                "text": "* BZD de\\Nelecci√≥n:",
                "children": [
                  {
                    "text": "* V√≠a venosa permeable (VPP): Lorazepam IV 0.1 mg/kg (ampolla 4 mg) (1)",
                    "children": []
                  },
                  {
                    "text": "* Sin VPP: Midazolam IM 0.2 mg/kg (ampolla 10 mg) (2)",
                    "children": []
                  }
                ]
              },
              {
                "text": "* Tiamina: 90-300 mg (3)",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "Estudio Crisis\\NConvulsiva en Urgencias",
        "children": [
          {
            "text": "Situaciones que deben ser incluidas en el\\N\"Estudio\" de un evento convulsivo:",
            "children": [
              {
                "text": "Mala adherencia a f√°rmacos (niveles s√©ricos de VPA, FNT, FBT, CBZ)",
                "children": []
              },
              {
                "text": "‚Üë Peso (reajuste de f√°rmacos a peso)",
                "children": []
              },
              {
                "text": "Descompensaci√≥n por foco infeccioso (urinario, respiratorio, men√≠ngeo, far√≠ngeo)",
                "children": []
              },
              {
                "text": "Descompensante metab√≥lico (hipo/hiperglicemia, hipo/hipernatremia, hipocalcemia, hipomagnesemia, hipofosfatemia)",
                "children": []
              },
              {
                "text": "Encefalopat√≠a hep√°tica/ur√©mica",
                "children": []
              },
              {
                "text": "Consumo OH o privaci√≥n",
                "children": []
              },
              {
                "text": "Privaci√≥n de horas de sue√±o",
                "children": []
              },
              {
                "text": "F√°rmacos que ‚Üì umbral convulsivante (antibi√≥ticos, neurol√©pticos, etc.)",
                "children": []
              },
              {
                "text": "Realizaci√≥n de TC de cerebro si corresponde",
                "children": []
              },
              {
                "text": "Punci√≥n lumbar si todos los factores anteriores resultan normales",
                "children": []
              }
            ]
          },
          {
            "text": "Estudio\\Nalterado?",
            "children": [
              {
                "text": "Si",
                "children": [
                  {
                    "text": "GCS<15 o no basal",
                    "children": [
                      {
                        "text": "Observaci√≥n/Hospitalizaci√≥n",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "GCS=15 o basal",
                    "children": [
                      {
                        "text": "Alta Policl√≠nico Primera Crisis o Epilepsia Descompensada",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "No",
                "children": [
                  {
                    "text": "Puede Manejo\\NAmbulatorio?",
                    "children": [
                      {
                        "text": "Si",
                        "children": [
                          {
                            "text": "Alta Policl√≠nico Primera Crisis o Epilepsia Descompensada",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "No",
                        "children": [
                          {
                            "text": "Observaci√≥n/Hospitalizaci√≥n",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Flujograma de Manejo de\\NStatus Epil√©ptico",
        "children": [
          {
            "text": "Elegir 1",
            "children": [
              {
                "text": "Levetiracetam 30-40 mg/kg (m√°x 4 g) en 5-10 minutos",
                "children": []
              },
              {
                "text": "Fenito√≠na 20 mg/kg infusi√≥n a 50 mg/minuto",
                "children": []
              },
              {
                "text": "Valproico 30-40 mg/kg infusi√≥n a 200 mg/min",
                "children": []
              }
            ]
          },
          {
            "text": "Resoluci√≥n\\NCl√≠nica",
            "children": [
              {
                "text": "S√≠",
                "children": [
                  {
                    "text": "Traslado Cama UTI/UTIN",
                    "children": []
                  }
                ]
              },
              {
                "text": "No",
                "children": [
                  {
                    "text": "Traslado Cama UCI (solicitar EEG precoz/continuo)",
                    "children": []
                  },
                  {
                    "text": "Opci√≥n 1",
                    "children": [
                      {
                        "text": "Midazolam bolo 0.2 mg/kg, luego infusi√≥n 0.1-0.3 mg/kg/h",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "Opci√≥n 2",
                    "children": [
                      {
                        "text": "Propofol bolo 1-2 mg/kg, luego infusi√≥n 1-3 mg/kg/h",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "Resoluci√≥n\\NCl√≠nica",
            "children": [
              {
                "text": "S√≠",
                "children": [
                  {
                    "text": "Sedaci√≥n con meta supresi√≥n cl√≠nica o EEG, por 24 h o hasta resoluci√≥n de factor causal",
                    "children": []
                  }
                ]
              },
              {
                "text": "No",
                "children": [
                  {
                    "text": "Evaluaci√≥n Neurol√≥gica para esquema de tercera l√≠nea",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "Notas:",
            "children": [
              {
                "text": "* La selecci√≥n de sedaci√≥n debe ser realizada considerando antecedentes previos y per√≠odo estimado de sedaci√≥n por el tratante.",
                "children": []
              },
              {
                "text": "* Debe considerase inicialmente una dosis de sedoanalgesia suficiente para suprimir cl√≠nicamente la actividad epil√©ptica.",
                "children": []
              },
              {
                "text": "* La titulaci√≥n de la sedaci√≥n para alcanzar una meta electroencefalogr√°fica de \"Estallido supresi√≥n\" (Burst Suppression) o\\N\"Beta farmacol√≥gico\" debe realizarse √∫nicamente con monitoreo EEG y con evidencia de trazados de status epil√©ptico.",
                "children": []
              }
            ]
          }
        ]
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1633",
      "title": "ACV: ESCALAS DE UTILIDAD CL√çNICA"
    },
    {
      "id": "map_1689",
      "title": "SPRINTT (2021)\\NSarcopenia and Physical\\NFragility in Older People:\\NMulti-component Treatment\\N\\n‚≠ê Ejercicio + nutrici√≥n reduce\\ndiscapacidad en fragilidad f√≠sica\\ncon sarcopenia"
    },
    {
      "id": "map_1785",
      "title": "ELDERCARE-AF (2020)\\NEdoxaban Low-Dose for\\NEldeRly patiEnts with\\NAtrial Fibrillation\\N\\n‚≠ê Edoxaban 15mg reduce ACV 66%\\nvs placebo en muy ancianos\\nno candidatos a ACO est√°ndar"
    },
    {
      "id": "map_1885",
      "title": "ACV: ESCALAS DE\\NUTILIDAD CL√çNICA"
    },
    {
      "id": "map_1640",
      "title": "Aciclovir (ACV) versus Valaciclovir (VACV)"
    }
  ],
  "source_file": "Flujogramas de Manejo de PatologiÃÅa NeuroloÃÅgica-2024-1.smmx",
  "created": "2026-02-07T15:43:04.351173"
}